Zensar Technologies announced its Q2FY26 results, reporting a 4.2% year-over-year revenue growth in reported currency and 3.4% in constant currency, reaching $162.8M. The company saw sequential QoQ growth of 0.5% in reported currency. Key sectors like Banking & Financial Services and Healthcare & Life Sciences drove growth, while the launch of ZenseAl, their new Al platform, is expected to further boost innovation.
Financial Performance Highlights
Zensar’s revenue for Q2FY26 reached $162.8 million, reflecting a 4.2% YoY growth in reported currency and 3.4% growth in constant currency. The company also saw a sequential QoQ growth of 0.5% in reported currency. Gross Margins stood at 31.0%, a sequential increase of 50bps QoQ.
Sector-Specific Growth
Several sectors contributed to Zensar’s positive performance in Q2FY26:
Banking and Financial Services: Reported a sequential QoQ revenue growth of 5.6% and quarterly YoY growth of 11.0% in reported currency.
Healthcare and Life Sciences: Showed a sequential QoQ revenue growth of 3.9% and quarterly YoY growth of 11.3% in reported currency.
Manufacturing and Consumer Services: Registered a sequential QoQ revenue growth of 0.1% and quarterly YoY growth of 0.1% in reported currency.
Regional Performance
Zensar experienced varied performance across different geographic regions:
US Region: Reported a sequential QoQ decline of 1.9% but a quarterly YoY growth of 2.7% in reported currency.
Europe Region: Showed a sequential QoQ growth of 5.2% and quarterly YoY growth of 6.0% in reported currency.
Africa Region: Reported a sequential QoQ growth of 6.9% and quarterly YoY growth of 9.8% in reported currency.
ZenseAl Platform Launch
Zensar launched ZenseAl, its next-generation platform designed to enhance Experience, Engineering, and Engagement value proposition. The company aims to harness artificial intelligence to create a lasting impact for clients and drive innovation.
Order Book and Profitability
Zensar’s order book stood at $158.7M for the current quarter. Utilization improved by 50 bps to 84.8%. EBITDA stood at 15.4% and PAT at 12.8%, showcasing a commitment to consistent profitability.
Source: BSE
